Ocular COO sells 1,099 shares at $10.24 each
The COO executed a small, pre-arranged sale of OCUL shares to cover tax withholding tied to RSU vesting, leaving a sizable direct share position.
Rhea-AI Filing Summary
OCULAR THERAPEUTIX, INC (OCUL) reported that its Chief Operating Officer, Donald Notman, sold 1,099 shares of common stock on August 31, 2026, at a weighted average price of $10.24 per share in an open-market transaction. The sale was executed under a durable automatic sale instruction to satisfy tax withholding from restricted stock units vesting on August 29, 2026, and is described as non-discretionary. Following this transaction, Notman held 366,529 shares directly, which include 1,272 shares acquired under the company’s Amended and Restated 2014 Employee Stock Purchase Plan on June 30, 2026.
Positive
- None.
Negative
- None.
Insider Trade Summary
Net Seller: 1,099 shares
Net Sell
1 txn
Insider
Notman Donald
Role
Chief Operating Officer
Sold
1,099 shs ($11K)
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Sale | Common Stock F1, F2, F3 | 1,099 | $10.24 | $11K |
Holdings After Transaction:
Common Stock — 366,529 shares (Direct)
Footnotes (3)
- F1. Represents shares of common stock of Ocular Therapeutix, Inc. (the "Corporation") sold, pursuant to a durable automatic sale instruction adopted by the reporting person on May 13, 2022, effecting the sell-to-cover election of the reporting person to satisfy tax withholding obligations in connection with the vesting of restricted stock units on August 29, 2026. The sales do not represent a discretionary trade by the reporting person.
- F2. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $10.1600 to $10.3800, inclusive. The reporting person undertakes to provide to the Corporation, any security holder of the Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) to this Form 4.
- F3. Includes 1,272 shares of common stock acquired under the Corporation's Amended and Restated 2014 Employee Stock Purchase Plan on June 30, 2026.
Key Figures
Shares sold: 1,099 shares
Weighted average sale price: $10.24 per share
Sale price range: $10.16–$10.38 per share
+2 more
5 metrics
Shares sold
1,099 shares
Common stock sale by OCUL COO on August 31, 2026
Weighted average sale price
$10.24 per share
Open-market sale on August 31, 2026
Sale price range
$10.16–$10.38 per share
Range of prices for multiple sale transactions on August 31, 2026
Shares held after transaction
366,529 shares
Direct holdings of COO after August 31, 2026 sale
ESPP shares included in holdings
1,272 shares
Acquired under Amended and Restated 2014 Employee Stock Purchase Plan on June 30, 2026
Key Terms
durable automatic sale instruction, sell-to-cover election, restricted stock units, weighted average price, +1 more
5 terms
durable automatic sale instruction regulatory
"sold, pursuant to a durable automatic sale instruction adopted by the reporting person"
sell-to-cover election financial
"effecting the sell-to-cover election of the reporting person to satisfy tax"
restricted stock units financial
"tax withholding obligations in connection with the vesting of restricted stock units"
Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.
weighted average price financial
"The price reported in Column 4 is a weighted average price."
Weighted average price is the average price of a security where each trade or component is counted according to its size, so bigger trades pull the average more than smaller ones. Think of it like calculating the average cost of a grocery haul where items you bought more of have greater influence on the final per-item cost. Investors use it to understand the true average price paid or received, judge execution quality, and compare trading performance against market movement.
Employee Stock Purchase Plan financial
"acquired under the Corporation's Amended and Restated 2014 Employee Stock Purchase Plan"
An employee stock purchase plan is a company program that lets workers buy shares through small payroll deductions, often at a discount to the market price and after a set offering period. Think of it like a workplace savings plan that turns into ownership: it encourages employees to share in the company’s success and can create predictable buying or selling of stock that investors watch because it affects supply, demand and employee incentives.
FAQ
What insider transaction did OCUL report for its COO on August 31, 2026?
OCULAR THERAPEUTIX, INC reported that COO Donald Notman sold 1,099 shares of common stock on August 31, 2026, in an open-market transaction at a weighted average price of $10.24 per share.
Was the OCUL COO’s August 2026 sale discretionary?
The company reports that the sales do not represent a discretionary trade by the COO and were made pursuant to a durable automatic sale instruction previously adopted on May 13, 2022.
AI-generated analysis. How Rhea-AI works. Not financial advice.
